1. Investment Snapshot
2. Thesis
3. Valuation & Price Target
4. Business & Product Moat
5. People & Governance
6. Market & Macro
7. Financial Quality
8. Risk Register
9. Prediction Market
10. 𝕏 Posts
Discussion
Loading...
Loading...
1. Investment Snapshot
2. Thesis
3. Valuation & Price Target
4. Business & Product Moat
5. People & Governance
6. Market & Macro
7. Financial Quality
8. Risk Register
9. Prediction Market
10. 𝕏 Posts
Discussion
1. Investment Snapshot
2. Capital Structure
3. Valuation
Discussion
Symbol
AVLN
Event Date
2026-04-30
Sector
Health Care
Subsector
Pharmaceuticals
Offer Range
—
Shares Offered
16.67M
Shares Outstanding Pre-IPO
461.46M
502.04M
—
Implied Upside vs Midpoint
$00.00Description
—
Post-IPO economic shares by class.
| Class | Shares | % Economic |
|---|---|---|
Convertible preferred stock (Series A, B, C-1, C-2, D) | 460.23M | 91.7% |
Common stock, $0.001 par value (listed) 1 vote per share (standard common stock assumed) | 41.81M | 8.3% |
| Total economic shares | 502.04M | 100% |